Univariate analysis revealed that 289 patients with MASLD with ALT levels ≤ 30 U/L in both cohorts were older than those with stages 0–2, with significant differences in age, type-2 DM, hypertension, AST levels, platelet counts, albumin levels, HbA1c levels, and the FIB-4 index. This evidence concerns the gene GPT and hypertensive disorder.